CID 134442338

Enrupatinib

Structural Information

Molecular Formula
C27H26N6O3
SMILES
CC1=NC=C(C=C1)COC2=C(C=C(C=C2)NC3=C(C4=NC(=CN=C4C=C3)N5CCOCC5)C#N)OC
InChI
InChI=1S/C27H26N6O3/c1-18-3-4-19(15-29-18)17-36-24-8-5-20(13-25(24)34-2)31-22-6-7-23-27(21(22)14-28)32-26(16-30-23)33-9-11-35-12-10-33/h3-8,13,15-16,31H,9-12,17H2,1-2H3
InChIKey
UGKFKFGVNJJPOL-UHFFFAOYSA-N
Compound name
6-[3-methoxy-4-[(6-methylpyridin-3-yl)methoxy]anilino]-3-morpholin-4-ylquinoxaline-5-carbonitrile
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

12
Patents

482.20663 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 483.21391 215.2
[M+Na]+ 505.19585 222.5
[M-H]- 481.19935 218.6
[M+NH4]+ 500.24045 214.1
[M+K]+ 521.16979 213.4
[M+H-H2O]+ 465.20389 193.1
[M+HCOO]- 527.20483 223.7
[M+CH3COO]- 541.22048 218.7
[M+Na-2H]- 503.18130 216.6
[M]+ 482.20608 209.1
[M]- 482.20718 209.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe